# Sweetch Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sweetch-health

- Industry: Healthcare IT
- Headquarters: Tel Aviv-Yafo, Israel
- Website: www.sweetch.com
- Total disclosed funding: $36M
- Latest round: Series A (Jul 19, 2021)
- Investors on record: 12

## About

Sweetch Health Ltd. specializes in hyper-personalized digital health solutions aimed at improving health outcomes for individuals with chronic conditions through innovative technology.Founded in 2013 in Tel Aviv-Yafo, Israel, Sweetch Health Ltd. develops digital health solutions centered on chronic disease management. The company has pivoted towards utilizing artificial intelligence and emotional intelligence technologies to enhance user engagement. Keren Shavit is the founder, and Dana Chanan serves as the CEO. In July 2021, Sweetch raised USD 20.00 mn in a Series A funding round led by Entree Capital, with participation from various investors, bringing the total amount raised to USD 20.00 mn.Sweetch offers a comprehensive suite of hyper-personalized digital health solutions designed to support individuals managing chronic conditions. Central to Sweetch's offerings is its fully automated Precision Engagement Platform, which leverages behavioral science combined with artificial intelligence (AI) and emotional intelligence (EI) to tailor interventions based on real-time user data. The platform incorporates Just-in-Time Adaptive Interventions (JITAI) that provide users with actionable recommendations at optimal moments, addressing areas such as medication adherence, physical activity, nutrition, and mental health. The end users primarily include individuals with chronic conditions like diabetes, obesity, cardiovascular diseases, autoimmune disorders, and oncology patients. The company’s solutions are primarily marketed in North America and Europe, where it collaborates with healthcare providers, payers, and wellness programs to enhance patient engagement and improve overall health outcomes.Sweetch's revenue generation model is structured around partnerships and subscription services with healthcare organizations and providers. The company enters into contractual agreements with clients that may include healthcare systems, insurance companies, and wellness programs, allowing them to integrate Sweetch's digital health solutions into their offerings. Clients pay for access to the platform, facilitating a direct-to-business transaction structure. Revenue may be derived from licensing fees or user-based subscriptions, which grant healthcare entities the ability to provide personalized health interventions to their patient populations. Sweetch's flagship offerings, such as its medication adherence and behavioral change programs, form the core of its revenue stream, while the company continues to expand its reach through strategic partnerships in various international markets.The recent USD 20.00 mn funding from July 2021 is earmarked for further global expansion and the advancement of its artificial intelligence (AI) and emotional intelligence (EI) technologies. Sweetch aims to enhance and launch new products that cater specifically to the needs of chronic condition management. The company plans to enter additional international markets, particularly targeting regions in Europe and North America over the coming years.

## Funding rounds

- Series A, Jul 19, 2021, $20M — Noaber Foundation, Entree Capital, OurCrowd, InsurTech.vc Management, Qure Ventures, FinTLV Ventures, Philips Health Technology Ventures, Tal Capital, Kortex Ventures
- Series A, May 28, 2020, $10M — OurCrowd
- Series A, Feb 25, 2019, $1.5M — OurCrowd, Philips Health Technology Ventures
- Series A, Apr 7, 2016, $3.5M — Pontifax Venture Capital, LionBird, OurCrowd, Philips Health Technology Ventures
- Seed, Apr 1, 2015, $0.8M — SeedIL Ventures

## Investors

- SeedIL Ventures (https://capitalatlas.ai/funds/seedil-ventures) — Seed
- Pontifax Venture Capital (https://capitalatlas.ai/funds/pontifax-venture-capital) — Series A
- LionBird (https://capitalatlas.ai/funds/lionbird) — Series A
- OurCrowd (https://capitalatlas.ai/funds/ourcrowd) — Series A
- Philips Health Technology Ventures (https://capitalatlas.ai/funds/philips-health-technology-ventures) — Series A
- Noaber Foundation — Series A
- Entree Capital (https://capitalatlas.ai/funds/entree-capital) — Series A
- InsurTech.vc Management (https://capitalatlas.ai/funds/insurtech-vc-management) — Series A
- Qure Ventures (https://capitalatlas.ai/funds/qure-ventures) — Series A
- FinTLV Ventures (https://capitalatlas.ai/funds/fintlv-ventures) — Series A
- Tal Capital (https://capitalatlas.ai/funds/tal-capital) — Series A
- Kortex Ventures (https://capitalatlas.ai/funds/kortex-ventures) — Series A